Home / Going-concern warnings / Verrica Pharmaceuticals Inc.
Filed 2025-05-13 路 Form 10-Q 路 Accession 0000950170-25-070452 micro
Price before filing: $5.06 (2025-05-12 close, split/dividend-adjusted)
Market cap at flag: $52.2M (2025-05-13) 路 Latest: $76.7M (2026-10-16)
| Window | VRCA | SPY | vs SPY | |
|---|---|---|---|---|
| 30 days | +33.2% | +3.6% | +29.6% | 2025-06-12 |
| 90 days | +32.4% | +9.4% | +23.0% | 2025-08-11 |
| 180 days | -23.5% | +17.6% | -41.1% | 2025-11-10 |
Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.
90 days before the flag: 1 insider sold $3K (1 sale)
30 days after: none reported.
| Date | Insider | Type | Shares | Price | Value | 10b5-1 plan | Source |
|---|---|---|---|---|---|---|---|
| 2025-03-17 | Hayes Christopher G. CHIEF LEGAL OFFICER | Sale | 4,315 | $0.65 | $3K | no | Form 4 |
| 2025-05-13: red flag filed | |||||||
Open-market purchases and sales (Form 4 codes P and S) by officers, directors and 10% owners, by transaction date, from 2025-02-12 to 2025-06-12. Excludes option exercises, grants, gifts and tax withholding. Amended filings replace the originals; joint filings count once. Foreign private issuers do not file Form 4. Many insider sales are pre-scheduled (10b5-1 plans) and are not by themselves a sign of wrongdoing.
"The Company plans to address the conditions that raise substantial doubt regarding its ability to continue as a going concern by, among other things, obtaining additional funding through equity offerings, debt financing and refinancings, collaborations, strategic alliances and/or licensing arrangements."
Quoted from the filing. Source
The filing states that substantial doubt exists about the company's ability to continue as a going concern: it may not have enough cash to last the next 12 months. Expect dilution, debt deals or worse. An auditor's going-concern paragraph is the strongest form of this warning.
Source: management disclosure in Form 10-Q (period 2025-03-31)
Why this score: quarterly (unaudited) disclosure
Read the original filing on SEC.gov →
Not investment advice. Automated summary; verify against the filing.
The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.
Subscribe to the newsletter →
The signup form didn't load here (often an ad or privacy blocker). This opens beehiiv's secure signup page.
Form not showing? Subscribe on beehiiv →
Newsletter delivered by beehiiv. See our privacy policy.